Trial Profile
Clinical Trials Insight: 700030689
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2009
Price :
$35
*
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Incyte Corporation
- 20 Feb 2008 New trial record.